The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump | Editorial

The article discusses the future of mRNA vaccines, which emerged as a success story during the COVID-19 pandemic. It highlights how the rapid development of these vaccines, enabled by relaxed regulatory constraints and scientific collaboration, suggests that loosening traditional constraints could accelerate major scientific advances. The article notes that the extensive scientific and logistic infrastructure built during the pandemic is now being used to explore the application of mRNA technology to other diseases, such as flu, HIV, and cancer. Until recently, the US, which invested over $10 billion in mRNA development, appeared poised to reap the scientific and commercial rewards. However, the article states that the second Trump administration has rejected the mRNA technology, with the US health secretary, Robert F. Kennedy Jr., actively undermining and sabotaging the US's own success. The administration has announced a "coordinated wind-down" of federal funding for mRNA research, cancelling an additional $500 million in funding for 22 projects. The article suggests that despite the US's recent actions, the future of mRNA vaccines appears secure, with or without the support of the Trump administration. The technology's potential to address a wide range of diseases makes it a significant scientific breakthrough that will likely continue to be developed and explored globally.